Immune ribonucleic acid (I-RNA) in the treatment of metastatic renal cell carcinoma.
De Vinci
C
C
First Division of Urology, M. Malpighi Hospital, Bologna, Italy.
Pizza
G
G
Severini
G
G
Cuzzocrea
D
D
Corrado
F
F
D000328:Adult; D000818:Animals; D001859:Bone Neoplasms / Q000556:secondary / Q000628:therapy; D001932:Brain Neoplasms / Q000556:secondary / Q000628:therapy; D002292:Carcinoma, Renal Cell / Q000556:secondary / Q000628:therapy*; D002464:Cell Migration Inhibition; D004306:Dose-Response Relationship, Immunologic; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D007680:Kidney Neoplasms / Q000628:therapy*; D007962:Leukocytes / Q000276:immunology; D008113:Liver Neoplasms / Q000556:secondary / Q000628:therapy; D008175:Lung Neoplasms / Q000556:secondary / Q000628:therapy; D008297:Male; D008875:Middle Aged; D012313:RNA / Q000276:immunology* / Q000627:therapeutic use; D014407:Tumor Cells, Cultured
C013674:RNA, immune; D012313:RNA